BLAUSTEIN MARC (Chief Operating Officer) sold 10.0% of their position (3.64K shares) of FINCH THERAPEUTICS GROUP, INC. on the open market
Open‑market sale worth $5.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/25/2022ACC: 0000899243-22-034125
Officer· Chief Operating Officer
Since Sep 2021
-3.64K
Net shares
Net seller
$5.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.64K
Price / share
$1.39
Trade value
$5.05K
% of position
10.0%
10/21/2022
36.25K→32.61K
Total
Net shares
−3.64K
Net value
-$5.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/21/2022 | S · Sale | −3.64K | $1.39 | $5.05K | 10.0% | 36.25K | 32.61K |
| Total | −3.64K | -$5.05K | ||||||
Derivative Transactions0
No derivative transactions reported